GYRE THERAPEUTICS, INC. (GYRE) › Weighted Average Diluted SharesGYRE THERAPEUTICS, INC. (GYRE) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2009-12-31: 25.64M2010-12-31: 30.15M2011-12-31: 31.64M2012-12-31: 33.48M2021-12-31: 30.64M2022-12-31: 75.69M2023-12-31: 65.83M2024-12-31: 102.29M2025-12-31: 103.18M103.18M2009-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31103.18M+0.9%2026-03-13From 2025-01-012024-12-31102.29M+55.4%2026-03-13From 2024-01-012023-12-3165.83M-13.0%2025-03-17From 2023-01-012022-12-3175.69M+147.0%2024-03-27From 2022-01-012021-12-3130.64M—2023-03-30From 2021-01-012012-12-3133.48M+5.8%2013-03-15From 2012-01-012011-12-3131.64M+4.9%2013-03-15From 2011-01-012010-12-3130.15M+17.6%2013-03-15From 2010-01-012009-12-3125.64M—2012-03-06From 2009-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)